Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on November 27, 2007
JNCI Journal of the National Cancer Institute 2007 99(23):1816-1817; doi:10.1093/jnci/djm212
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
99/23/1816    most recent
djm212v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kerlikowske, K.
Right arrow Articles by Walker, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kerlikowske, K.
Right arrow Articles by Walker, R.
Related Collections
Right arrowRelated Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

CORRESPONDENCE

Response: Re: Declines in Invasive Breast Cancer and Use of Postmenopausal Hormone Therapy in a Screening Mammography Population

Karla Kerlikowske, Diana S. M. Buist, Rod Walker

Affiliations of authors: Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, and General Internal Medicine Section, San Francisco Veterans Affairs Medical Center, San Francisco, CA (KK); Group Health Center for Health Studies, Seattle, WA (DSMB, RW)

Correspondence to: Karla Kerlikowske, MD, General Internal Medicine Section, San Francisco Veterans Affairs Medical Center, 111A1, 4150 Clement Street, San Francisco, CA 94121 (e-mail: karla.kerlikowske@ucsf.edu).

The first 10% of the full text of this article appears below.

The magnitude of decline in invasive breast cancer has been remarkably consistent across studies (1–4). Two of the main proposed causes for the decline are a decrease in screening mammography and a decline in use of postmenopausal hormone therapy (HT). We reported a decline in invasive cancer of 5% annually or 15% over . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Correspondence

Re: Declines in Invasive Breast Cancer and Use of Postmenopausal Hormone Therapy in a Screening Mammography Population
Anthony S. Robbins and Christina A. Clarke
J Natl Cancer Inst 2007 99: 1815. [Extract] [Full Text] [PDF]

Re: Declines in Invasive Breast Cancer and Use of Postmenopausal Hormone Therapy in a Screening Mammography Population
Benjamin O. Anderson
J Natl Cancer Inst 2007 99: 1815-1816. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
K. Kerlikowske, D. S. M. Buist, R. Walker, and D. L. Miglioretti
Response: Re: Declines in Invasive Breast Cancer and Use of Postmenopausal Hormone Therapy in a Screening Mammography Population
J Natl Cancer Inst, April 16, 2008; 100(8): 599 - 599.
[Full Text] [PDF]